Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Filed Chapter 11
|
|
ABLE LABORATORIES INC (ABRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2006 |
8-K
| Quarterly results |
| 03/06/2006 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/14/2006 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2006 |
SC 13G/A
| WELLINGTON MANAGEMENT CO LLP reports a 0% stake in Able Laboratories, Inc. |
| 02/10/2006 |
SC 13G/A
| RS Investment Management reports a 0% stake in Able Laboratories, Inc. |
| 11/17/2005 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 10/25/2005 |
8-K
| Acquisition/merger/asset purchase announced |
| 08/17/2005 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/22/2005 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 07/20/2005 |
8-K
| Filed for Chapter 11 |
| 07/15/2005 |
8-K
| Entry into a Material Definitive Agreement |
| 07/08/2005 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 0% stake in ABLE LABORATORIES, INC. |
| 07/08/2005 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Able Laboratories, Inc. Announces Resignation of President Cranbury, NJ, July 7, 2005 - Able Laboratories, Inc. today announced that Robert G. Mauro, the Company's President and interim Chief Executive Officer and a director, has tendered his resignation and the Company has accepted his resignation from each of those positions. The Company is presently seeking an appropriate replacement to lead the Company in addressing the Company's previously disclosed regulatory issues, including its recall of all products and its suspension of all manufacturing operations. Meanwhile, day-to-day activities are expected to continue to be overseen by the board of directors and carried out by the Company's senior management team and its retained consultants. The ongoing disruption in the Company's operatio...",
"Able Laboratories, Inc. Cancels Annual Stockholder Meeting Cranbury, NJ, June 30, 2005 - Able Laboratories, Inc. announced today that it is canceling the annual meeting of stockholders scheduled to take place on July 8, 2005. At this time, the Company, its management team and its retained consultants are continuing to focus the Company's resources on addressing the Company's previously disclosed regulatory issues, including its recall of all products and its suspension of all manufacturing operations. The ongoing disruption in the Company's operations caused by the recall and the suspension of manufacturing activities has had, and will continue to have, a material adverse effect on the Company's results of operations and financial position. Able can give no assurance as to if or when it wi..." |
|
| 06/15/2005 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Able Laboratories, Inc. Workforce Reduction Cranbury, NJ, June 9, 2005 - Able Laboratories, Inc. announced today that it is making further staff reductions. Able anticipates making further reductions in staff in order to conserve assets and assist it in retaining key employees as it continues to address pending regulatory issues, evaluates its strategic alternatives and formulates and executes its plan for future operations. As the Company previously announced, the disruption in its operations and reduction in its workforce is expected to have a material adverse effect on its results of operations and financial position. At this time, the Company can give no assurance as to when it will be able to resume manufacturing operations. Further information on Able may be found on the Company's we...",
"Able Laboratories, Inc. Announces New Annual Meeting Date Cranbury, NJ, June 10, 2005 - Able Laboratories, Inc. announced today that it will postpone its scheduled 2005 annual meeting of stockholders to a later time and place. The adjournment of the meeting will be held at the offices of Foley Hoag LLP, 155 Seaport Boulevard, Boston, MA 02210, at 9:00 a.m. on July 8, 2005. Able decided to adjourn the meeting to a later date in order to permit further communications with stockholders prior to the meeting and to enable management to continue to focus on the Company's ongoing efforts to address current operating issues as announced in Able's recent press releases. Further information on Able may be found on the Company's web site, www.ablelabs.com." |
|
| 06/07/2005 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/06/2005 |
SC 13G
| ATTICUS MANAGEMENT LLC reports a 6.3% stake in Able Laboratories, Inc. |
| 05/27/2005 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/25/2005 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 05/12/2005 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 05/10/2005 |
10-Q
| Quarterly Report for the period ended March 31, 2005 |
| 05/03/2005 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/29/2005 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/04/2005 |
4
| HAHN ELLIOT F (Director) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Disposed of 20,000 shares
@ $0
Acquired 20,000 shares
@ $0 |
|
| 03/15/2005 |
10-K
| Annual Report for the period ended December 31, 2004 |
| 03/11/2005 |
4
| WADEKAR DHANANJAY G (C.E.O., Chairman & Secretary) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Gifted 2,000 shares
@ $0
Exercised 46,667 options to buy
@ $1.875, valued at
$87.5k
Exercised 2,000 options to buy
@ $1.875, valued at
$3.8k
|
|
| 03/11/2005 |
4
| SCHNEIDER F HOWARD (Vice Pres., Special Projects) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Sold 11,332 shares
@ $22.75, valued at
$257.8k
Exercised 11,332 options to buy
@ $3.75, valued at
$42.5k
|
|
| 03/11/2005 |
4
| HARIBHAKTI KAMLESH (Director - Product Development) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Sold 10,000 shares
@ $22.75, valued at
$227.5k
|
|
| 03/10/2005 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 03/04/2005 |
4
| TREPPEL JERRY (Director) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 03/04/2005 |
4
| Tierney David S (Director) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Granted 20,000 options to buy
@ $21.54, valued at
$430.8k
|
|
| 03/04/2005 |
4
| SILVERMAN HARRY (Director) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 03/04/2005 |
4
| HAHN ELLIOT F (Director) has filed a Form 4 on ABLE LABORATORIES INC|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 02/15/2005 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 10.3% stake in ABLE LABORATORIES, INC. |
| 02/14/2005 |
SC 13G
| RS Investment Management reports a 7.7% stake in Able Laboratories, Inc. |
|
|
|